Next Vial Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.1/10
Best for: compounded GLP-1, LegitScript-certified, with a named pharmacy partner
Next Vial scores highest on state availability and ease of access.
Semaglutide
then $199/mo ongoing
Tirzepatide
then $249/mo ongoing
Price checked on Next Vial’s site,
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not stated
Coaching
Not stated
No insurance needed · Vetted by our editors
Fully online GLP-1 telehealth marketplace connecting patients with licensed providers for compounded semaglutide and tirzepatide injections, including microdose options. LegitScript certified with medication dispensed through Manifest Pharmacy (Greer, SC). No membership required: one transparent price covers consultation, medication, and free shipping. Serves 49 states.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money
Vetted alternatives to Next Vial
Ro
Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help
Editorial score · methodology
Collective
Best for: the lowest flat medication price if you can absorb an annual membership fee
Editorial score · methodology
CoreAge Rx
Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose
Editorial score · methodology
Next Vial at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $199/mo (after intro offer) ($78 intro price)
- What's included
- Medication · Consult · Shipping
- Availability
- 49 states
- FDA status
- No FDA warning letter on record
How we scored Next Vial
Each dimension is scored algorithmically from Next Vial’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.
Value25%
6.5/10At $199/mo (after intro offer), Next Vial runs about 11% above the $179 median for GLP-1 providers (each program's lowest listed ongoing monthly price for compounded semaglutide), with an intro price of $78.
Effectiveness25%
7.9/10Next Vial offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
7.1/10Online intake and platform experience (consult included in the price); 7 platform features disclosed.
Trust & Safety15%
7.0/10Core details confirmed by our editors; no FDA warning letters on file.
Accessibility10%
8.0/10Next Vial is available in 49 states: all but Alaska.
Support10%
5.6/10Next Vial provides standard clinician follow-up; no extended coaching or community program is disclosed.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Next Vial review
Last checked November 2026- Confirmed current pricing across 2 dose/plan tiers
- Confirmed availability in 49 states
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the provider's public sign-up flow, stopping before payment
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: medium.
What we checked
- Provider's own pricing page
- $199–$249/mo across 2 dose/plan tiers (checked November 2026)
- State pharmacy licensing & LegitScript status
- LegitScript certified
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with Next Vial
We walked Next Vial’s public signup flow in July 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Take a 100% online health questionnaire / intake form.
- 2A U.S. board-certified physician reviews records and prescriptions.
- 3Medications are delivered free from accredited pharmacies.
- No price is shown before or after the questionnaire on the pages reviewed, despite an 'upfront pricing' claim.
- States 'no insurance, no waitlist, free delivery' and 'no membership required.'
- Offers compounded and microdose semaglutide and tirzepatide.
GLP-1 medications Next Vial offers
Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
Ready to get started?
Plans and promotions change often, so check Next Vial's current pricing and active discounts before you decide.
What we like
- LegitScript certified with named pharmacy partner (Manifest Pharmacy, Greer, SC)
- No membership fees: one all-in price covering consultation, medication, and shipping
- Compounded semaglutide, tirzepatide, and microdose options available
- Free rushed shipping; serves 49 states nationwide
- Board-certified physician oversight with ongoing provider support
Watch-outs
- Lowest monthly rates require prepaying 6 or 12 months up front
- Compounded medications are not FDA-approved
- Labs and nutritional coaching not disclosed
- Microdose pricing not published on product page
- Alaska not listed among served states
Is Next Vial worth it?
The short version of what Next Vial offers is compounded GLP-1, LegitScript-certified, with a named pharmacy partner. New patients start at $78/month as an intro price, but the price steps up to $199/month after the intro period, so treat the headline number as an intro offer, not the standing rate. No single feature of its GLP-1 program sets it apart from the category on its own, so the price and terms below are the things to compare.
Worth knowing before you sign up: Next Vial offers a microdosing option and is LegitScript-certified.
How much Next Vial costs
- Compounded semaglutide is currently $78/month on an intro offer, regularly $199/month, at that tier.
- Compounded tirzepatide is currently $127/month on an intro offer, regularly $249/month, for that option.
Because Next Vial's headline figure is listed as “after intro offer”, we don't set it against the roughly $179 market median for this category. That median is each program's lowest listed ongoing monthly price for compounded semaglutide, so compare Next Vial with the month-to-month prices of the alternatives below instead.
Belle Health (about $199/month) is one of the closest alternatives to weigh Next Vial against.
Medications: what Next Vial prescribes
Next Vial prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro), the two most-studied weight-loss molecules on the market today. Rather than brand-name pens, you get a compounded formulation from a licensed pharmacy, which is why the monthly cost is lower. Just know compounded drugs aren't FDA-approved as finished products, the standard caveat in this market.
Who Next Vial is best for, and who should skip it
A good fit if you…
- want a straightforward telehealth GLP-1 program and are comfortable comparing it against the alternatives below.
Look elsewhere if you…
- specifically want an FDA-approved brand-name pen instead of a compounded formulation, which this provider doesn't fill.
- need to bill insurance, since like most of this market it's cash-pay with no claims filed on your behalf.
Trust, safety, and medical oversight
Next Vial is available in 49 states, and we found no FDA warning letter on file for it. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation, and we explain how in our scoring methodology.
Bottom line
Next Vial's intro price of $78 takes some of the cost out of the start, but plan around the $199/month standing price, since that is what you pay from then on. To see Next Vial against the wider field, use our ranked semaglutide providers; the patient guide to compounded versus brand-name GLP-1s covers what to weigh before choosing a compounded program.
The Bottom Line
Next Vial scores highest on state availability and ease of access.
Ready to start with Next Vial?
From $199/mo (after intro offer). See current pricing and start your free consultation.
Next Vial might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Head-to-head
Compare Next Vial vs…
Next Vial scores7.1/10
Side-by-side pricing, medications and scores. Pick a matchup.
Next Vial vs Amazon One Medical
Amazon One Medical scores 8.5/10

Next Vial vs Vytora Health
Vytora Health scores 8.4/10
Scores are our independent editorial ratings out of 10.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Next Vial review:
Sources & methodology (as of November 2026)
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Next Vial's current pricing
Plans from $199/mo (after intro offer). Start your free consultation to check eligibility and today's price.